ANAB
Anaptysbio, IncCompany with tickers: ANAB
CIK
1370053
CUSIP
032724106
Shares Outstanding
29,100,902
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $25,556,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $60,193,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | — | ||||
| Operating Income | $-34,637,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-52,884,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-1.84 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-1.84 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |